Global Acute Myeloid Leukemia Treatment Market Size, Status and Forecast 2021-2027

急性骨髄性白血病(AML)治療の世界市場規模・現状・予測2021年-2027年

◆タイトル:Global Acute Myeloid Leukemia Treatment Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR0074
◆調査・発行会社:QYResearch
◆発行日:2021年4月
◆ページ数:99
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、主要地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥444,600見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥666,900見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥889,200見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査資料では、急性骨髄性白血病(AML)治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(DCレジメン、AVDレジメン、VCDレジメン)、用途別市場規模(病院、クリニック、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・急性骨髄性白血病(AML)治療の市場動向
・企業の競争状況、市場シェア
・急性骨髄性白血病(AML)治療の種類別市場規模(DCレジメン、AVDレジメン、VCDレジメン)
・急性骨髄性白血病(AML)治療の用途別市場規模(病院、クリニック、その他)
・急性骨髄性白血病(AML)治療の北米市場規模2016-2027(アメリカ、カナダ)
・急性骨髄性白血病(AML)治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・急性骨髄性白血病(AML)治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・急性骨髄性白血病(AML)治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・急性骨髄性白血病(AML)治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Ambit Biosciences Corporation、Celgene Corporation、Cephalon、Clavis Pharma、Eisai、Genzyme Corporation、Sunesis Pharmaceuticals)
・結論

Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 19 years of age diagnosed with leukemia have acute myeloid leukemia. The risk of acute myeloid leukemia is closely associated with age. About 90% of acute myeloid leukemia is diagnosed in middle age.

Market Analysis and Insights: Global Acute Myeloid Leukemia Treatment Market
The global Acute Myeloid Leukemia Treatment market size is projected to reach US$ 964.7 million by 2026, from US$ 561.8 million in 2019, at a CAGR of 7.9% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acute Myeloid Leukemia Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acute Myeloid Leukemia Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acute Myeloid Leukemia Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acute Myeloid Leukemia Treatment market.

Global Acute Myeloid Leukemia Treatment Scope and Market Size
Acute Myeloid Leukemia Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acute Myeloid Leukemia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
DC regimen
AVD Regimen
VCD regimen

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Ambit Biosciences Corporation
Celgene Corporation
Cephalon
Clavis Pharma
Eisai
Genzyme Corporation
Sunesis Pharmaceuticals

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Myeloid Leukemia Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 DC regimen
1.2.3 AVD Regimen
1.2.4 VCD regimen
1.3 Market by Application
1.3.1 Global Acute Myeloid Leukemia Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Acute Myeloid Leukemia Treatment Market Perspective (2016-2027)
2.2 Acute Myeloid Leukemia Treatment Growth Trends by Regions
2.2.1 Acute Myeloid Leukemia Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acute Myeloid Leukemia Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Acute Myeloid Leukemia Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Acute Myeloid Leukemia Treatment Industry Dynamic
2.3.1 Acute Myeloid Leukemia Treatment Market Trends
2.3.2 Acute Myeloid Leukemia Treatment Market Drivers
2.3.3 Acute Myeloid Leukemia Treatment Market Challenges
2.3.4 Acute Myeloid Leukemia Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Acute Myeloid Leukemia Treatment Players by Revenue
3.1.1 Global Top Acute Myeloid Leukemia Treatment Players by Revenue (2016-2021)
3.1.2 Global Acute Myeloid Leukemia Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Acute Myeloid Leukemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acute Myeloid Leukemia Treatment Revenue
3.4 Global Acute Myeloid Leukemia Treatment Market Concentration Ratio
3.4.1 Global Acute Myeloid Leukemia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Myeloid Leukemia Treatment Revenue in 2020
3.5 Acute Myeloid Leukemia Treatment Key Players Head office and Area Served
3.6 Key Players Acute Myeloid Leukemia Treatment Product Solution and Service
3.7 Date of Enter into Acute Myeloid Leukemia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Acute Myeloid Leukemia Treatment Breakdown Data by Type
4.1 Global Acute Myeloid Leukemia Treatment Historic Market Size by Type (2016-2021)
4.2 Global Acute Myeloid Leukemia Treatment Forecasted Market Size by Type (2022-2027)

5 Acute Myeloid Leukemia Treatment Breakdown Data by Application
5.1 Global Acute Myeloid Leukemia Treatment Historic Market Size by Application (2016-2021)
5.2 Global Acute Myeloid Leukemia Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Acute Myeloid Leukemia Treatment Market Size (2016-2027)
6.2 North America Acute Myeloid Leukemia Treatment Market Size by Type
6.2.1 North America Acute Myeloid Leukemia Treatment Market Size by Type (2016-2021)
6.2.2 North America Acute Myeloid Leukemia Treatment Market Size by Type (2022-2027)
6.2.3 North America Acute Myeloid Leukemia Treatment Market Size by Type (2016-2027)
6.3 North America Acute Myeloid Leukemia Treatment Market Size by Application
6.3.1 North America Acute Myeloid Leukemia Treatment Market Size by Application (2016-2021)
6.3.2 North America Acute Myeloid Leukemia Treatment Market Size by Application (2022-2027)
6.3.3 North America Acute Myeloid Leukemia Treatment Market Size by Application (2016-2027)
6.4 North America Acute Myeloid Leukemia Treatment Market Size by Country
6.4.1 North America Acute Myeloid Leukemia Treatment Market Size by Country (2016-2021)
6.4.2 North America Acute Myeloid Leukemia Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Acute Myeloid Leukemia Treatment Market Size (2016-2027)
7.2 Europe Acute Myeloid Leukemia Treatment Market Size by Type
7.2.1 Europe Acute Myeloid Leukemia Treatment Market Size by Type (2016-2021)
7.2.2 Europe Acute Myeloid Leukemia Treatment Market Size by Type (2022-2027)
7.2.3 Europe Acute Myeloid Leukemia Treatment Market Size by Type (2016-2027)
7.3 Europe Acute Myeloid Leukemia Treatment Market Size by Application
7.3.1 Europe Acute Myeloid Leukemia Treatment Market Size by Application (2016-2021)
7.3.2 Europe Acute Myeloid Leukemia Treatment Market Size by Application (2022-2027)
7.3.3 Europe Acute Myeloid Leukemia Treatment Market Size by Application (2016-2027)
7.4 Europe Acute Myeloid Leukemia Treatment Market Size by Country
7.4.1 Europe Acute Myeloid Leukemia Treatment Market Size by Country (2016-2021)
7.4.2 Europe Acute Myeloid Leukemia Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Acute Myeloid Leukemia Treatment Market Size (2016-2027)
8.2 Asia-Pacific Acute Myeloid Leukemia Treatment Market Size by Type
8.2.1 Asia-Pacific Acute Myeloid Leukemia Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acute Myeloid Leukemia Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acute Myeloid Leukemia Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Acute Myeloid Leukemia Treatment Market Size by Application
8.3.1 Asia-Pacific Acute Myeloid Leukemia Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acute Myeloid Leukemia Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acute Myeloid Leukemia Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Acute Myeloid Leukemia Treatment Market Size by Region
8.4.1 Asia-Pacific Acute Myeloid Leukemia Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acute Myeloid Leukemia Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Acute Myeloid Leukemia Treatment Market Size (2016-2027)
9.2 Latin America Acute Myeloid Leukemia Treatment Market Size by Type
9.2.1 Latin America Acute Myeloid Leukemia Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Acute Myeloid Leukemia Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Acute Myeloid Leukemia Treatment Market Size by Type (2016-2027)
9.3 Latin America Acute Myeloid Leukemia Treatment Market Size by Application
9.3.1 Latin America Acute Myeloid Leukemia Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Acute Myeloid Leukemia Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Acute Myeloid Leukemia Treatment Market Size by Application (2016-2027)
9.4 Latin America Acute Myeloid Leukemia Treatment Market Size by Country
9.4.1 Latin America Acute Myeloid Leukemia Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Acute Myeloid Leukemia Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Acute Myeloid Leukemia Treatment Market Size (2016-2027)
10.2 Middle East & Africa Acute Myeloid Leukemia Treatment Market Size by Type
10.2.1 Middle East & Africa Acute Myeloid Leukemia Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acute Myeloid Leukemia Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acute Myeloid Leukemia Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Acute Myeloid Leukemia Treatment Market Size by Application
10.3.1 Middle East & Africa Acute Myeloid Leukemia Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acute Myeloid Leukemia Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acute Myeloid Leukemia Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Acute Myeloid Leukemia Treatment Market Size by Country
10.4.1 Middle East & Africa Acute Myeloid Leukemia Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acute Myeloid Leukemia Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Ambit Biosciences Corporation
11.1.1 Ambit Biosciences Corporation Company Details
11.1.2 Ambit Biosciences Corporation Business Overview
11.1.3 Ambit Biosciences Corporation Acute Myeloid Leukemia Treatment Introduction
11.1.4 Ambit Biosciences Corporation Revenue in Acute Myeloid Leukemia Treatment Business (2016-2021)
11.1.5 Ambit Biosciences Corporation Recent Development
11.2 Celgene Corporation
11.2.1 Celgene Corporation Company Details
11.2.2 Celgene Corporation Business Overview
11.2.3 Celgene Corporation Acute Myeloid Leukemia Treatment Introduction
11.2.4 Celgene Corporation Revenue in Acute Myeloid Leukemia Treatment Business (2016-2021)
11.2.5 Celgene Corporation Recent Development
11.3 Cephalon
11.3.1 Cephalon Company Details
11.3.2 Cephalon Business Overview
11.3.3 Cephalon Acute Myeloid Leukemia Treatment Introduction
11.3.4 Cephalon Revenue in Acute Myeloid Leukemia Treatment Business (2016-2021)
11.3.5 Cephalon Recent Development
11.4 Clavis Pharma
11.4.1 Clavis Pharma Company Details
11.4.2 Clavis Pharma Business Overview
11.4.3 Clavis Pharma Acute Myeloid Leukemia Treatment Introduction
11.4.4 Clavis Pharma Revenue in Acute Myeloid Leukemia Treatment Business (2016-2021)
11.4.5 Clavis Pharma Recent Development
11.5 Eisai
11.5.1 Eisai Company Details
11.5.2 Eisai Business Overview
11.5.3 Eisai Acute Myeloid Leukemia Treatment Introduction
11.5.4 Eisai Revenue in Acute Myeloid Leukemia Treatment Business (2016-2021)
11.5.5 Eisai Recent Development
11.6 Genzyme Corporation
11.6.1 Genzyme Corporation Company Details
11.6.2 Genzyme Corporation Business Overview
11.6.3 Genzyme Corporation Acute Myeloid Leukemia Treatment Introduction
11.6.4 Genzyme Corporation Revenue in Acute Myeloid Leukemia Treatment Business (2016-2021)
11.6.5 Genzyme Corporation Recent Development
11.7 Sunesis Pharmaceuticals
11.7.1 Sunesis Pharmaceuticals Company Details
11.7.2 Sunesis Pharmaceuticals Business Overview
11.7.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Treatment Introduction
11.7.4 Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Treatment Business (2016-2021)
11.7.5 Sunesis Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Acute Myeloid Leukemia Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of DC regimen
Table 3. Key Players of AVD Regimen
Table 4. Key Players of VCD regimen
Table 5. Global Acute Myeloid Leukemia Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Acute Myeloid Leukemia Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Acute Myeloid Leukemia Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Acute Myeloid Leukemia Treatment Market Share by Regions (2016-2021)
Table 9. Global Acute Myeloid Leukemia Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Acute Myeloid Leukemia Treatment Market Share by Regions (2022-2027)
Table 11. Acute Myeloid Leukemia Treatment Market Trends
Table 12. Acute Myeloid Leukemia Treatment Market Drivers
Table 13. Acute Myeloid Leukemia Treatment Market Challenges
Table 14. Acute Myeloid Leukemia Treatment Market Restraints
Table 15. Global Acute Myeloid Leukemia Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Acute Myeloid Leukemia Treatment Market Share by Players (2016-2021)
Table 17. Global Top Acute Myeloid Leukemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Myeloid Leukemia Treatment as of 2020)
Table 18. Ranking of Global Top Acute Myeloid Leukemia Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Acute Myeloid Leukemia Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Acute Myeloid Leukemia Treatment Product Solution and Service
Table 22. Date of Enter into Acute Myeloid Leukemia Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Acute Myeloid Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Acute Myeloid Leukemia Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Acute Myeloid Leukemia Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Acute Myeloid Leukemia Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Acute Myeloid Leukemia Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Acute Myeloid Leukemia Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Acute Myeloid Leukemia Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Acute Myeloid Leukemia Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Acute Myeloid Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Acute Myeloid Leukemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Acute Myeloid Leukemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Acute Myeloid Leukemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Acute Myeloid Leukemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Acute Myeloid Leukemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Acute Myeloid Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Acute Myeloid Leukemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Acute Myeloid Leukemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Acute Myeloid Leukemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Acute Myeloid Leukemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Acute Myeloid Leukemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Acute Myeloid Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Acute Myeloid Leukemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Acute Myeloid Leukemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Acute Myeloid Leukemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Acute Myeloid Leukemia Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Acute Myeloid Leukemia Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Acute Myeloid Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Acute Myeloid Leukemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Acute Myeloid Leukemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Acute Myeloid Leukemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Acute Myeloid Leukemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Acute Myeloid Leukemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Acute Myeloid Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Acute Myeloid Leukemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Acute Myeloid Leukemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Acute Myeloid Leukemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Acute Myeloid Leukemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Acute Myeloid Leukemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Ambit Biosciences Corporation Company Details
Table 63. Ambit Biosciences Corporation Business Overview
Table 64. Ambit Biosciences Corporation Acute Myeloid Leukemia Treatment Product
Table 65. Ambit Biosciences Corporation Revenue in Acute Myeloid Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 66. Ambit Biosciences Corporation Recent Development
Table 67. Celgene Corporation Company Details
Table 68. Celgene Corporation Business Overview
Table 69. Celgene Corporation Acute Myeloid Leukemia Treatment Product
Table 70. Celgene Corporation Revenue in Acute Myeloid Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 71. Celgene Corporation Recent Development
Table 72. Cephalon Company Details
Table 73. Cephalon Business Overview
Table 74. Cephalon Acute Myeloid Leukemia Treatment Product
Table 75. Cephalon Revenue in Acute Myeloid Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 76. Cephalon Recent Development
Table 77. Clavis Pharma Company Details
Table 78. Clavis Pharma Business Overview
Table 79. Clavis Pharma Acute Myeloid Leukemia Treatment Product
Table 80. Clavis Pharma Revenue in Acute Myeloid Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 81. Clavis Pharma Recent Development
Table 82. Eisai Company Details
Table 83. Eisai Business Overview
Table 84. Eisai Acute Myeloid Leukemia Treatment Product
Table 85. Eisai Revenue in Acute Myeloid Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 86. Eisai Recent Development
Table 87. Genzyme Corporation Company Details
Table 88. Genzyme Corporation Business Overview
Table 89. Genzyme Corporation Acute Myeloid Leukemia Treatment Product
Table 90. Genzyme Corporation Revenue in Acute Myeloid Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 91. Genzyme Corporation Recent Development
Table 92. Sunesis Pharmaceuticals Company Details
Table 93. Sunesis Pharmaceuticals Business Overview
Table 94. Sunesis Pharmaceuticals Acute Myeloid Leukemia Treatment Product
Table 95. Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 96. Sunesis Pharmaceuticals Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Myeloid Leukemia Treatment Market Share by Type: 2020 VS 2027
Figure 2. DC regimen Features
Figure 3. AVD Regimen Features
Figure 4. VCD regimen Features
Figure 5. Global Acute Myeloid Leukemia Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Others Case Studies
Figure 9. Acute Myeloid Leukemia Treatment Report Years Considered
Figure 10. Global Acute Myeloid Leukemia Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Acute Myeloid Leukemia Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Acute Myeloid Leukemia Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Acute Myeloid Leukemia Treatment Market Share by Regions (2022-2027)
Figure 14. Global Acute Myeloid Leukemia Treatment Market Share by Players in 2020
Figure 15. Global Top Acute Myeloid Leukemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Myeloid Leukemia Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Acute Myeloid Leukemia Treatment Revenue in 2020
Figure 17. Global Acute Myeloid Leukemia Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Acute Myeloid Leukemia Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Acute Myeloid Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Acute Myeloid Leukemia Treatment Market Share by Type (2016-2027)
Figure 21. North America Acute Myeloid Leukemia Treatment Market Share by Application (2016-2027)
Figure 22. North America Acute Myeloid Leukemia Treatment Market Share by Country (2016-2027)
Figure 23. United States Acute Myeloid Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Acute Myeloid Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Acute Myeloid Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Acute Myeloid Leukemia Treatment Market Share by Type (2016-2027)
Figure 27. Europe Acute Myeloid Leukemia Treatment Market Share by Application (2016-2027)
Figure 28. Europe Acute Myeloid Leukemia Treatment Market Share by Country (2016-2027)
Figure 29. Germany Acute Myeloid Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Acute Myeloid Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Acute Myeloid Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Acute Myeloid Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Acute Myeloid Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Acute Myeloid Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Acute Myeloid Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Acute Myeloid Leukemia Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Acute Myeloid Leukemia Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Acute Myeloid Leukemia Treatment Market Share by Region (2016-2027)
Figure 39. China Acute Myeloid Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Acute Myeloid Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Acute Myeloid Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Acute Myeloid Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Acute Myeloid Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Acute Myeloid Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Acute Myeloid Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Acute Myeloid Leukemia Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Acute Myeloid Leukemia Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Acute Myeloid Leukemia Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Acute Myeloid Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Acute Myeloid Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Acute Myeloid Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Acute Myeloid Leukemia Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Acute Myeloid Leukemia Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Acute Myeloid Leukemia Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Acute Myeloid Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Acute Myeloid Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Acute Myeloid Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Ambit Biosciences Corporation Revenue Growth Rate in Acute Myeloid Leukemia Treatment Business (2016-2021)
Figure 59. Celgene Corporation Revenue Growth Rate in Acute Myeloid Leukemia Treatment Business (2016-2021)
Figure 60. Cephalon Revenue Growth Rate in Acute Myeloid Leukemia Treatment Business (2016-2021)
Figure 61. Clavis Pharma Revenue Growth Rate in Acute Myeloid Leukemia Treatment Business (2016-2021)
Figure 62. Eisai Revenue Growth Rate in Acute Myeloid Leukemia Treatment Business (2016-2021)
Figure 63. Genzyme Corporation Revenue Growth Rate in Acute Myeloid Leukemia Treatment Business (2016-2021)
Figure 64. Sunesis Pharmaceuticals Revenue Growth Rate in Acute Myeloid Leukemia Treatment Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[急性骨髄性白血病(AML)治療の世界市場規模・現状・予測2021年-2027年] (Global Acute Myeloid Leukemia Treatment Market Size, Status and Forecast 2021-2027 / QY21APR0074)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆